Evolving Pharmacovigilance Beyond a Cost Center
Safety is evolving rapidly. There is a major, emerging opportunity ...
Connected to the Future: Making Drug Safety Databases Transparent, E2B R3 Compliant and Cost-Effective
As different regulatory authorities have different timelines for adoption of these standards, E2B(R2) E2B(R3) will have to coexist. But having to operate two solutions creates huge complexities, unless you find a solution compliant with both. ArisGlobal LifeSphere Safety MultiVigilance is the only drug safety database solution provider thus far to provide full compliance to E2B R2 and E2B R3 standards for both import and export.
Chinese Pharmacovigilance: How Auto-Translation and Side-by-Side Dual Language Panels Can Reduce Your Manual Effort
LifeSphere Safety MultiVigilance (LSSMV) database system has auto-translation capabilities that can translate safety narratives from English to Chinese and vice versa using advanced machine-learning technology.
Best Practices in Safety Signal Analytics — Managing Today and Preparing for Tomorrow
With up to 30-50% annual growth in adverse event cases, how ...
Blog: Automation in ICSR Processing – Is Artificial Intelligence the Paradigm Shift in Pharmacovigilance?
Artificial intelligence (AI), machine learning, deep learning, natural language processing ...
Benefits of a True SaaS Safety System
The Shift to the Cloud Historically, firms relied heavily on ...
Best Practices for Digitally Transforming Pharmacovigilance Processes
On June 9th, 2020 ArisGlobal held a webinar titled “Pharmacovigilance and ...
Automation in Pharmacovigilance: A Real-World Implementation Story
In the last of our three-part blog series, we share the poll results to the question "What concerns do you have when it comes to automating PV process?" and analyze the responses. Read the blog to see how your responses might compare.
Benefits & Challenges of Artificial Intelligence in Pharmacovigilance
Pharmacovigilance is at a crossroads. The best, most innovative way forward for PV departments may well be automation, as they address the challenges (or market pull factors) and opportunities (or technology push capabilities).
Beat the Clock with Future-Ready ICH E2B R3 Compliant Safety Database Systems for Chinese Submissions
In order to stay compliant with NMPA requirements (submitting all post-marketing ADRs in ICH E2B (R3) format), drug manufacturers are required to procure an electronic safety database that is.....
